Cellid, Co., Ltd. (299660.KQ)

KRW 5500.0

(-7.25%)

Gross Profit Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual gross profit in 2023 was -2.66 Billion KRW , down -11.98% from previous year.
Cellid, Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was -807.79 Million KRW , down -53.3% from previous quarter.
Cellid, Co., Ltd. reported a annual gross profit of -2.37 Billion KRW in annual gross profit 2022, down -72.49% from previous year.
Cellid, Co., Ltd. reported a annual gross profit of -1.37 Billion KRW in annual gross profit 2021, down -180.27% from previous year.
Cellid, Co., Ltd. reported a quarterly gross profit of -807.79 Million KRW for 2024 Q2, down -53.3% from previous quarter.
Cellid, Co., Ltd. reported a quarterly gross profit of -662.97 Million KRW for 2023 Q1, down -32.41% from previous quarter.

Annual Gross Profit Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Gross Profit of Cellid, Co., Ltd. (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	-2.66 Billion KRW	-11.98%
2022	-2.37 Billion KRW	-72.49%
2021	-1.37 Billion KRW	-180.27%
2020	-491.99 Million KRW	-349.27%
2019	-109.5 Million KRW	-43.07%
2018	-76.54 Million KRW	-9.64%
2017	-69.81 Million KRW	-7.66%
2016	-64.84 Million KRW	-110.13%
2015	639.81 Million KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	-526.93 Million KRW	20.71%
2024 Q2	-807.79 Million KRW	-53.3%
2023 Q1	-662.97 Million KRW	-32.41%
2023 FY	-2.66 Billion KRW	-11.98%
2023 Q4	-664.53 Million KRW	0.55%
2023 Q3	-668.22 Million KRW	-0.06%
2023 Q2	-667.84 Million KRW	-0.73%
2022 Q4	-500.71 Million KRW	23.97%
2022 FY	-2.37 Billion KRW	-72.49%
2022 Q1	-639.12 Million KRW	-3.95%
2022 Q3	-658.6 Million KRW	-1.93%
2022 Q2	-646.16 Million KRW	-1.1%
2021 Q3	-598.62 Million KRW	-165.93%
2021 Q4	-614.81 Million KRW	-2.71%
2021 Q1	-490.73 Million KRW	-50283.37%
2021 Q2	907.95 Million KRW	285.02%
2021 FY	-1.37 Billion KRW	-180.27%
2020 Q4	-974 Thousand KRW	43.14%
2020 Q1	-759 Thousand KRW	-11.72%
2020 Q2	-742.05 Thousand KRW	2.23%
2020 Q3	-1.71 Million KRW	-130.85%
2020 FY	-491.99 Million KRW	-349.27%
2019 Q1	-1.02 Million KRW	-55.95%
2019 FY	-109.5 Million KRW	-43.07%
2019 Q4	-679.4 Thousand KRW	-47.7%
2019 Q3	-460 Thousand KRW	14.81%
2019 Q2	-540 Thousand KRW	47.08%
2018 Q2	-1.16 Million KRW	-7.08%
2018 FY	-76.54 Million KRW	-9.64%
2018 Q1	-1.09 Million KRW	-95.57%
2018 Q4	-654.36 Thousand KRW	0.0%
2017 FY	-69.81 Million KRW	-7.66%
2017 Q1	-517.4 Thousand KRW	0.0%
2017 Q4	-558.62 Thousand KRW	0.0%
2016 FY	-64.84 Million KRW	-110.13%
2015 FY	639.81 Million KRW	0.0%

Peer Gross Profit Comparison of Cellid, Co., Ltd.

Name	Gross Profit	Gross Profit Difference
Sam Chun Dang Pharm. Co., Ltd	94.48 Billion KRW	102.819%
Hyundai Bioscience Co., Ltd.	5.04 Billion KRW	152.836%
ST Pharm Co.,Ltd.	106.62 Billion KRW	102.498%
ABL Bio Inc.	65.5 Billion KRW	104.066%